Working… Menu

Borderline Pancreas Study: FOLFIRINOX +SBRT (GCC 1324)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01992705
Recruitment Status : Completed
First Posted : November 25, 2013
Last Update Posted : August 19, 2019
Information provided by (Responsible Party):
Department of Radiation Oncology, University of Maryland, Baltimore

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 27, 2018
Actual Study Completion Date : September 27, 2018